Att.1- JA 345__Redacted_.pdf

This is a Justification Review Document for a sole-source contract award to Curium US, LLC for radiopharmaceutical products supporting the William Beaumont Army Medical Center (WBAMC) in Fort Bliss, Texas. The contract is a 12-month follow-on definititive contract funded by FY26 Defense Health Program funds, valued at an undisclosed amount. The procurement involves acquiring multiple radiopharmaceutical items including CU64 DETECTNET, Technescan MAG3, Pulmotech MAA, Ultra Technekov, Uranium Shield, Sestamibi, Ultratag RBC, and I-123 USP Nal, totaling quantities ranging from 2 to 40 units.

The document details extensive market research conducted from May to September 2025, including procurement history review, industry feedback solicitation, manufacturer contacts, internet searches, and coordination with the Defense Logistics Agency. A sources sought notice yielded three responses, with one source deemed technically acceptable to provide depleted uranium (DU) generators. The radiopharmaceuticals will be used for nuclear medicine procedures, patient diagnostics, and medical imaging, with critical requirements including FDA-approved vendors, precise product matching, and strict monitoring of radioactive materials. The contract is being pursued as a sole-source procurement under FAR Part 13 simplified procedures for commercial items, with no anticipated competition.